| Market Cap | ₹82Cr |
| ROE | 12.56% |
| P/E Ratio(TTM) | 27.49 |
| EPS(TTM) | 4.62 |
| P/B Ratio | 3.45 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.30 |
| Book Value | 36.80 |
| Debt to Equity | 0.28 |
| Face Value | 10 |
| Managing Director | Narasimhan Arvind Varchaswi |
| Founded | 1995 |
| BSE Symbol | 531398 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 40.56 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 30.92 | ||
| Wockhardt | NA (0.00%) | -2228.87 | ||
| Natco Pharma | NA (0.00%) | 9.67 |